Thanks to our world-class researchers, state-of-the-art technologies and unrelenting focus on scientific excellence, Merck is at the forefront of discovering and developing innovative ways to treat and prevent disease.
Scientific innovation has always been the cornerstone of our company and that continues today. Today, we conduct research in a broad range of therapeutic categories – including cardiovascular, diabetes and endocrinology, neurosciences and ophthalmology, oncology, infectious diseases, and respiratory and immunology.
To help achieve our goal of saving and improving lives around the world, we have expanded our capabilities in new areas, such as biologics and biosimilars.
Did You Know?
The process of identifying and developing medicines is long and challenging. It begins by exploring the roots of a disease or condition. Which aspect of a disease should we target, and with what type of molecule?
If a candidate molecule proves promising, it then continues through years of rigorous testing and must obtain regulatory approval before it reaches the market. A very small fraction of the candidates that begin evaluation will ultimately survive the tough process of research, development and testing to finally become medicines.